Ozempic Litigation
A growing number of lawsuits allege that Ozempic and related weight management drugs cause severe gastrointestinal injuries. Plaintiffs in these cases claim that Novo Nordisk and Eli Lilly and Co., the makers of semaglutide medications for diabetes and weight loss, failed to adequately warn patients and health care providers about the potential risks associated with the medications.
Introduction to Ozempic Lawsuits
The actions in this Multidistrict Litigation, MDL No. 3094, are generally personal injury lawsuits alleging gastrointestinal injuries from taking glucagon-like peptide-1 receptor agonists or GLP-1 RAs—a class of medications prescribed for type 2 diabetes and weight loss.
The following drugs are the subject of the litigation:
- Manufactured by Novo Nordisk – Ozempic, Wegovy, and Rybelsus
- Manufactured by Eli Lilly and Co. – Trulicity and Mounjaro
The MDL has consolidated claims related to all these drugs. The lawsuits filed against Novo Nordisk and Eli Lilly allege that Ozempic and the other semaglutide drugs cause serious gastrointestinal complications, such as the following:
Gastroparesis
This condition affects the normal spontaneous movement of the stomach muscles, preventing them from emptying properly. Food can sit in the stomach too long, causing nausea and vomiting.
Intestinal obstruction or pseudo-obstruction
This is a potentially life-threatening condition in which the intestines are blocked or have severely impaired motility. Signs and symptoms include nausea, vomiting, distension, and obstipation with bowel dilation on CT imaging or X-ray imaging.
Other severe gastrointestinal injuries
These include acute pancreatitis or gallbladder disease.
Plaintiffs in these lawsuits argue that Novo Nordisk and Eli Lilly were aware of the potential gastroparesis, ileus, and bowel obstruction side effects of Ozempic and the other semaglutide prescriptions but failed to adequately warn patients and health care providers about these risks. Plaintiffs also allege that the drug manufacturing giants used aggressive and deceptive marketing to sell these medications. As a result, many individuals have suffered significant harm, leading to a surge in Ozempic claims against the drugmaker.
The Ozempic litigation is highly relevant for law firms representing clients who experienced severe gastrointestinal injuries after taking the medication. As the number of cases grows, attorneys must stay informed about the latest developments and understand the intricacies of these claims.
Timeline of Ozempic Lawsuit Developments
The Ozempic gastroparesis lawsuit has seen significant developments in recent months, with the formation of the MDL and the consolidation of cases across the United States. Here is an updated timeline for the Ozempic litigation:
The Judicial Panel on Multidistrict Litigation establishes MDL No. 3094 for Ozempic, Wegovy, Mounjaro, and other GLP-1 RA drugs. The cases are centralized in the U.S. District Court for the Eastern District of Pennsylvania, with Judge Gene E. K. Pratter presiding over the litigation. The MDL includes 18 actions pending in 11 districts and 37 potential tag-along actions.
New Jersey sees its first Ozempic suit, with the plaintiff claiming the medication caused kidney damage.
A Louisiana plaintiff files suit in the Ozempic gastroparesis litigation, alleging the drug caused “stomach paralysis.
As the MDL progresses, additional bellwether trials, settlements, or other notable events may occur. Staying current on these updates is essential for law firms involved in Ozempic cases, as they can provide valuable insights into the strengths and weaknesses of the litigation and help inform legal strategies.
The Role of Case Works in Ozempic Mass Tort Litigation
Case Works provides comprehensive case management services for mass tort litigation, including Ozempic lawsuits. Our team of experienced professionals understands these cases’ unique challenges and complexities and offers tailored solutions to help law firms efficiently manage large volumes of claims.
Our services encompass every stage of the case management process, including the following:
We can help your firm identify and screen potential clients to ensure they meet the criteria for the Ozempic MDL, such as documented use of the medication and a diagnosed gastrointestinal injury.
Our team can handle the time-consuming process of requesting, obtaining, and organizing medical records for each client, ensuring all relevant information is easily accessible.
We can assist in completing and submitting plaintiff fact sheets, which are essential for providing detailed information about each client's case.
Our advanced document management systems ensure all case-related materials are securely stored, organized, and easily searchable, saving your firm valuable time and resources.
We can help your firm maintain regular communication with clients, providing updates on their cases and the overall litigation progress and addressing any concerns they may have.
By partnering with Case Works, law firms can streamline their Ozempic litigation workload, ensuring each case receives the attention it deserves while freeing up attorneys’ time to focus on strategy and building compelling arguments.
How Law Firms Can Prepare
To effectively handle Ozempic lawsuits, law firms should consider the following key steps:
Thoroughly vet potential cases
It is essential to ensure that each potential client meets the criteria for the Ozempic MDL. The vetting process includes documenting the use of Ozempic, Wegovy, Rybelsus, or Mounjaro and determining a clear link between the medication’s use and the alleged injury.
Stay current on medical research
Attorneys should closely monitor the latest medical studies and expert opinions linking GLP-1 RA drugs to gastrointestinal complications. This information can be crucial in establishing causation and building the strongest cases.
Develop a clear communication strategy
With the potential for large numbers of clients in mass tort litigation, it is essential to have a well-defined communication plan in place. This strategy should include regular Ozempic lawsuit updates on individual case progress and broader developments in the MDL.
Interested in External Case Management?
Partnering with an experienced case management firm like Case Works can provide numerous benefits for law firms handling Ozempic lawsuits:
- Increased efficiency and scalability: Our team can help your firm manage many cases without sacrificing quality or attention to detail.
- Reduced administrative burden: By handling the day-to-day aspects of case management, we allow your attorneys to focus on legal strategy and client advocacy.
- Improved client communication and satisfaction: Our streamlined processes and regular communication help keep clients informed and engaged throughout the litigation process.
Our team has the expertise and resources to support your firm at every stage of the Ozempic litigation process, from intake to resolution. By leveraging our services, your firm can take on more cases and pursue the best possible outcomes for your clients.
Relevant Videos
Get Started With Case Works
If your law firm is involved in Ozempic litigation and seeks a reliable partner for case management, Case Works is here to help. Our comprehensive services and commitment to client success make us the ideal choice for managing your Ozempic cases.
Don’t let the complexities of mass tort litigation overwhelm your firm. Partner with Case Works and let us handle the details so you can focus on securing justice for your clients in the Ozempic lawsuits.
To learn more about how we can support your firm, contact us today to schedule a personalized consultation. Our knowledgeable team will discuss your specific needs and demonstrate how our solutions can help you achieve your goals in the Ozempic MDL.
